U-Chart Analysis:Sumitomo Pharma Co., Ltd.:4506

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Sumitomo Pharma Co., Ltd. Go to web site 4506 Medicals 東証プライム March 1, 2000 1949.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Sumitomo Pharma Co., Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Sumitomo Pharma Co., Ltd. Balance Sheet 2024年3月期 Sumitomo Pharma Co., Ltd. Balance Sheet 2023年3月期 Sumitomo Pharma Co., Ltd. Balance Sheet 2022年3月期 Sumitomo Pharma Co., Ltd. Balance Sheet 2021年3月期 Sumitomo Pharma Co., Ltd. Balance Sheet 2020年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Cash and Cash Equivalents 29,047 143,478 202,984 193,698 101,708
Other Current AssetsHelp 240,522 238,382 296,537 266,097 262,382
Tangible Fixed AssetsHelp 57,895 58,909 64,091 64,966 65,748
Intangible Fixed AssetHelp 195,652 329,314 398,692 383,406 421,029
Investments and OthersHelp 184,607 155,244 150,559 223,468 232,203
Total AssetsHelp 907,506 1,134,742 1,308,007 1,308,127 1,256,534
Total Current LiabilitiesHelp 618,076 483,865 456,156 463,698 698,844
Total Long-term LiabilitiesHelp 133,367 244,128 243,963 263,859 25,020
Shareholder's EquityHelp 156,063 406,749 607,888 580,570 532,670
Total LiabilitiesHelp 907,506 1,134,742 1,308,007 1,308,127 1,256,534

Sumitomo Pharma Co., Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Sumitomo Pharma Co., Ltd. Profit and Loss Account 2024年3月期 Sumitomo Pharma Co., Ltd. Profit and Loss Account 2023年3月期 Sumitomo Pharma Co., Ltd. Profit and Loss Account 2022年3月期 Sumitomo Pharma Co., Ltd. Profit and Loss Account 2021年3月期 Sumitomo Pharma Co., Ltd. Profit and Loss Account 2020年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Amount of Sales 314,558 555,544 560,035 515,952 482,732
Total Sales 314,558 555,544 560,035 515,952 482,732
Cost of SalesHelp 126,528 178,494 157,116 137,645 129,045
Other Costs and RevenueHelp 502,999 451,562 346,506 322,088 312,934
Total CostsHelp 629,527 630,056 503,622 459,733 441,979
Net RevenueHelp 188,030 377,050 402,919 378,307 353,687
Earnings Before TaxHelp -323,114 -47,920 82,961 77,851 83,947
Net IncomeHelp -314,969 -74,512 56,413 56,219 40,753
Net Income -314,969 -74,512 56,413 56,219 40,753

Sumitomo Pharma Co., Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Sumitomo Pharma Co., Ltd. Cash Flow Statement 2024年3月期 Sumitomo Pharma Co., Ltd. Cash Flow Statement 2023年3月期 Sumitomo Pharma Co., Ltd. Cash Flow Statement 2022年3月期 Sumitomo Pharma Co., Ltd. Cash Flow Statement 2021年3月期 Sumitomo Pharma Co., Ltd. Cash Flow Statement 2020年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Operating Cash Flow(OFC)Help -240,758 10,802 31,239 135,601 46,128
Investing Cash Flow(ICF)Help 33,036 52,419 -18,278 8,875 -312,684
Financing Cash FlowHelp 77,851 -146,817 -21,426 -57,215 231,081
Exchange Difference of Cash and Cash EquivalentsHelp 15,440 24,090 17,751 4,729 -113
Net Increase and Decrease in Cash and Cash Equivalentsn -114,431 -59,506 9,286 91,990 -35,588

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Sumitomo Pharma Co., Ltd.

Company where related level is highHelp

Daito Pharmaceutical Co.,Ltd.
HISAMITSU PHARMACEUTICAL CO.,INC.
R-TECH UENO,LTD.
Modalis Therapeutics Corporation
MORISHITA JINTAN CO.,LTD.
Kidswell Bio Corporation
Nxera Pharma Co., Ltd.
Cyfuse Biomedical K.K.
WAKAMOTO PHARMACEUTICAL CO.,LTD.
TAIKO PHARMACEUTICAL CO.,LTD.